ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+36.4%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$225M
AUM Growth
+$46M
Cap. Flow
+$12.5M
Cap. Flow %
5.58%
Top 10 Hldgs %
63.98%
Holding
58
New
15
Increased
15
Reduced
5
Closed
10

Top Buys

1
BLU
BELLUS Health Inc.
BLU
$6.57M
2
SRPT icon
Sarepta Therapeutics
SRPT
$4.59M
3
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$4.52M
4
BCAB icon
BioAtla
BCAB
$4M
5
UTHR icon
United Therapeutics
UTHR
$3.04M

Top Sells

1
VTGN icon
VistaGen Therapeutics
VTGN
$10M
2
RCUS icon
Arcus Biosciences
RCUS
$4.24M
3
OBIO icon
Orchestra BioMed
OBIO
$3.91M
4
DTIL icon
Precision BioSciences
DTIL
$3.28M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.98M

Sector Composition

1 Healthcare 93.74%
2 Financials 6.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
26
Vaxcyte
PCVX
$4.29B
$2.04M 0.88%
+85,000
New +$2.04M
PMVP icon
27
PMV Pharmaceuticals
PMVP
$77.4M
$1.84M 0.79%
154,500
+2,000
+1% +$23.8K
FULC icon
28
Fulcrum Therapeutics
FULC
$414M
$1.78M 0.77%
220,000
+20,000
+10% +$162K
ALT icon
29
Altimmune
ALT
$334M
$1.6M 0.69%
+125,000
New +$1.6M
IOVA icon
30
Iovance Biotherapeutics
IOVA
$901M
$1.47M 0.63%
153,639
-717
-0.5% -$6.87K
PYXS icon
31
Pyxis Oncology
PYXS
$118M
$1.32M 0.57%
669,158
+24,009
+4% +$47.3K
MRUS icon
32
Merus
MRUS
$5.1B
$1.18M 0.51%
59,000
-95,000
-62% -$1.9M
ALLK
33
DELISTED
Allakos
ALLK
$1.18M 0.51%
+192,500
New +$1.18M
RZLT icon
34
Rezolute
RZLT
$696M
$1.15M 0.49%
419,145
-225,991
-35% -$619K
IMGN
35
DELISTED
Immunogen Inc
IMGN
$669K 0.29%
+140,000
New +$669K
HZNP
36
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$248K 0.11%
4,000
-31,888
-89% -$1.98M
ESPR icon
37
Esperion Therapeutics
ESPR
$540M
$201K 0.09%
+30,000
New +$201K
IDYA icon
38
IDEAYA Biosciences
IDYA
$2.38B
$149K 0.06%
+10,000
New +$149K
SWTX
39
DELISTED
SpringWorks Therapeutics
SWTX
$143K 0.06%
5,000
– –
DICE
40
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$136K 0.06%
+6,700
New +$136K
ZNTL icon
41
Zentalis Pharmaceuticals
ZNTL
$126M
$108K 0.05%
+5,000
New +$108K
NGM
42
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$98K 0.04%
+7,500
New +$98K
KNTE
43
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$60K 0.03%
+5,000
New +$60K
TRVI icon
44
Trevi Therapeutics
TRVI
$854M
$56K 0.02%
36,302
+1,302
+4% +$2.01K
NUVB.WS icon
45
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$15K 0.01%
90,832
– –
BMEA icon
46
Biomea Fusion
BMEA
$114M
$10K ﹤0.01%
+1,000
New +$10K
ACAD icon
47
Acadia Pharmaceuticals
ACAD
$4.26B
– –
-71,500
Closed -$1.01M
DTIL icon
48
Precision BioSciences
DTIL
$59.8M
– –
-68,345
Closed -$3.28M
ENTA icon
49
Enanta Pharmaceuticals
ENTA
$189M
– –
-27,500
Closed -$1.3M
ITOS
50
DELISTED
iTeos Therapeutics
ITOS
– –
-62,000
Closed -$1.28M
1
2
3